NIMOTOP CAP 30MG DIN 00596442
Status: Cancelled Post Market
Holder: MILES CANADA INC. - PHARMACEUTICAL DIVISION
Molecule: NIMODIPINE
Health Canada record
| Active ingredient(s) | NIMODIPINE 30 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C08CA06 NIMODIPINE |
| Original market date | 31-Dec-1989 |
| Current status date | 02-Oct-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NIMODIPINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02325926 | NIMOTOP | LABORATOIRE X.0 | Tablet | NIMODIPINE 30 MG | Marketed |
| 02155923 | NIMOTOP - CAP 30MG | BAYER INC | Capsule | NIMODIPINE 30 MG | Cancelled Post Market |
| 01927124 | NIMOTOP IV 0.2MG/ML | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Liquid | NIMODIPINE 0.2 MG | Cancelled Post Market |
International API supply for NIMODIPINE
3 valid EDQM Certificates of Suitability from 3 holders. 5 active FDA Drug Master Files.
Request a quote for NIMOTOP CAP 30MG